Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Melissa A Burgess"'
Autor:
Erin Jensen, Evan J Lipson, Martin A Cheever, Adil Daud, Brent A Hanks, Shailender Bhatia, Thomas Olencki, Kari Kendra, Mizuho Kalabis, William H Sharfman, Ragini R Kudchadkar, Philip A Friedlander, Sunil A Reddy, Brian C Boulmay, Adam Riker, Melissa A Burgess, Candice Church, Tomoko Akaike, Michi M Shinohara, Bob Salim, Blanca Homet Moreno
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 4 (2021)
Background Merkel cell carcinoma (MCC) is an aggressive skin cancer associated with poor survival. Programmed cell death-1 (PD-1) pathway inhibitors have shown high rates of durable tumor regression compared with chemotherapy for MCC. The current stu
Externí odkaz:
https://doaj.org/article/73de26009f964e2780583bb59aad23b0
Autor:
Seth M. Pollack, Neeta Somaiah, Dejka M. Araujo, Mihaela Druta, Brian A. Van Tine, Melissa A. Burgess, Sant P. Chawla, Mahesh Seetharam, Scott H. Okuno, Chet Bohac, Michael Chen, Sergey Yurasov, Steven Attia
Publikováno v:
Cancer Medicine, Vol 9, Iss 13, Pp 4593-4602 (2020)
Abstract Background Outcomes data regarding advanced synovial sarcoma (SS) and myxoid/round cell liposarcoma (MRCL) are limited, consisting primarily of retrospective series and post hoc analyses of clinical trials. Methods In this multi‐center ret
Externí odkaz:
https://doaj.org/article/2292b5dd195549049e097c6c426bed12
Autor:
Mrinal Gounder, Ravin Ratan, Thierry Alcindor, Patrick Schöffski, Winette T. van der Graaf, Breelyn A. Wilky, Richard F. Riedel, Allison Lim, L. Mary Smith, Stephanie Moody, Steven Attia, Sant Chawla, Gina D’Amato, Noah Federman, Priscilla Merriam, Brian A. Van Tine, Bruno Vincenzi, Charlotte Benson, Nam Quoc Bui, Rashmi Chugh, Gabriel Tinoco, John Charlson, Palma Dileo, Lee Hartner, Lore Lapeire, Filomena Mazzeo, Emanuela Palmerini, Peter Reichardt, Silvia Stacchiotti, Howard H. Bailey, Melissa A. Burgess, Gregory M. Cote, Lara E. Davis, Hari Deshpande, Hans Gelderblom, Giovanni Grignani, Elizabeth Loggers, Tony Philip, Joseph G. Pressey, Shivaani Kummar, Bernd Kasper
Publikováno v:
New England Journal of Medicine. 388:898-912
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6b2f4eb68309977641e312c313c71cc
https://doi.org/10.1056/nejmoa2210140
https://doi.org/10.1056/nejmoa2210140
Autor:
Céleste Lebbé, Jeffrey Russell, Caroline Robert, Gülseren Güzel, Thilo Gambichler, Jérémy Lambert, Nicola Fazio, Bartosz Chmielowski, Alexia Marrel, Jean-Jacques Grob, Melissa A. Burgess, Murtuza Bharmal, Sandra P. D’Angelo
Publikováno v:
The Patient
Background and Objective Avelumab is approved for the treatment of metastatic Merkel cell carcinoma, a rare aggressive skin cancer with a poor prognosis. The aim of this qualitative study embedded in a clinical trial was to explore patient experience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1148ba45aecc7596449b65eb08c7ac46
https://doi.org/10.1007/s40271-020-00428-5
https://doi.org/10.1007/s40271-020-00428-5
Autor:
Mihaela Druta, Steven Attia, Michael Chen, Dejka M. Araujo, Chet Bohac, Sant P. Chawla, Neeta Somaiah, Melissa Amber Burgess, Brian A. Van Tine, Scott H. Okuno, Sergey Yurasov, Seth M. Pollack, Mahesh Seetharam
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 9, Iss 13, Pp 4593-4602 (2020)
Cancer Medicine, Vol 9, Iss 13, Pp 4593-4602 (2020)
Background Outcomes data regarding advanced synovial sarcoma (SS) and myxoid/round cell liposarcoma (MRCL) are limited, consisting primarily of retrospective series and post hoc analyses of clinical trials. Methods In this multi‐center retrospectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac8f922eb4068e555fc6b1b0ec801328
https://doi.org/10.1002/cam4.3039
https://doi.org/10.1002/cam4.3039
Autor:
Piotr Rutkowski, Giovanni Grignani, Enrica Teresa Tanda, Melissa Amber Burgess, Sadhna Shankar, Natalie Prinzi, Jean-jaques Grob, Michele Guida, Shailender Bhatia, Jennifer Pulini, Chuan Tian, Céleste Lebbé
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundRetifanlimab (INCMGA00012) is a humanized, hinge-stabilized immunoglobulin G4 kappa (IgG4κ), anti-programmed cell death protein (PD)-1 monoclonal antibody with safety and clinical pharmacology that are characteristic for the class. Evaluat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f71205e6c5f4ac7b1600fed931bcded
https://doaj.org/article/db63b1bf4b0b42ea978e3082b7d0ba5f
https://doaj.org/article/db63b1bf4b0b42ea978e3082b7d0ba5f
Autor:
Sminu Bose, Matthew Ingham, Li Chen, Bose Kochupurakkal, Adrian Marino-Enriquez, Jacob B. Allred, Suzanne George, Steven Attia, Melissa Amber Burgess, Mahesh Seetharam, Sosipatros Alexandros Boikos, Nam Bui, James Lin Chen, Julia Lee Close, Gregory Michael Cote, S. Percy Ivy, Biswajit Das, Geoffrey Shapiro, Gary K. Schwartz
Publikováno v:
Journal of Clinical Oncology. 40:11509-11509
11509 Background: uLMS is an aggressive sarcoma subtype of smooth muscle origin. Chemotherapy provides limited benefit for advanced disease. 18-25% of uLMS harbor deleterious alterations in homologous recombination (HR) DNA repair genes. uLMS exhibit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72c5cf53571d5dbe0b366976047c8cc3
https://doi.org/10.1200/jco.2022.40.16_suppl.11509
https://doi.org/10.1200/jco.2022.40.16_suppl.11509
Autor:
Mohamad Adham Salkeni, Anthony Paul Conley, James Lin Chen, Elizabeth J. Davis, Melissa Amber Burgess, Albiruni Ryan Abdul Razak, Nancy Moore, Katherine V. Ferry-Galow, Kristin K. Fino, King Leung Fung, Ralph E. Parchment, Jared C. Foster, Christina Rosenberger, Geraldine Helen O'Sullivan Coyne, Naoko Takebe, Elad Sharon, James H. Doroshow, Alice P. Chen
Publikováno v:
Journal of Clinical Oncology. 40:11528-11528
11528 Background: Chondrosarcoma is one of the most common bone malignancies in adults, and the third most common in pediatric patients (pts). The most prevalent subtype, conventional chondrosarcoma, is a slow growing tumor that is historically known
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::604b5f9eac5d22a82039ab9516e3abd0
https://doi.org/10.1200/jco.2022.40.16_suppl.11528
https://doi.org/10.1200/jco.2022.40.16_suppl.11528
Autor:
Melissa A. Burgess, Shannon L. Puhalla
Publikováno v:
Frontiers in Oncology, Vol 4 (2014)
No longer is histology solely predictive of cancer treatment and outcome. There is an increasing influence of tumor genomic characteristics on therapeutic options. Both breast and ovarian cancers are at higher risk of development in patients with BRC
Externí odkaz:
https://doaj.org/article/80dc813864c04a30aea15574b58b81a1
Publikováno v:
Journal of the National Comprehensive Cancer Network. 16:1424-1428
Gastrointestinal stromal tumors (GISTs) represent 1% of alimentary tract neoplasms. Up to 90% of GISTs are driven by activating mutations in tyrosine kinase KIT or PDGFRα genes. Imatinib mesylate is a tyrosine kinase inhibitor that has recently been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb7db45d5f1a8adcca6f9db8c5436b63
https://doi.org/10.6004/jnccn.2018.7063
https://doi.org/10.6004/jnccn.2018.7063